WORK PACKAGE TREATMENT CHALLENGES Dr.Thomas Legl Member of Executive Committee EURO –TC Director Kur- und Gesundheitszentrum Knappenhof/Austria ICAA,,

Slides:



Advertisements
Similar presentations
Multicultural Wellness Center “Providing Culture Centered Treatment to Diverse Communities.”
Advertisements

CHILD HEALTH NURSING.
Provider Spring Meeting 2012 Sirrilla D. Blackmon, MSW, LCSW, LCAC Deputy Director Provider & Community Relations, Certification/Licensure Division of.
David Oyat Abang NAFOPHANU Uganda
Section 17: Treatment Planning. 2 Icebreaker How do you define treatment planning?
Colorado Department of Healthcare Policy and FinancingColorado Department of Healthcare Policy and Financing Improving health care access and outcomes.
Overview of the 2010 work programme Paul Griffiths, Roland Simon, Rosemary de Sousa Scientific Committee meeting, Lisbon, November 2009.
Translating Research to Practice in Treating Substance Use Disorders Richard Rawson, Ph. D. UCLA Drug Abuse Research Center Matrix Institute on Addictions.
Broekaert E., Ph.D. Vandevelde S., Ma.Ed Vanderplasschen W., Ma.Ed. Soyez V., Ma.Ed. Poppe A., Ma.Ed. Two Decades of ‘Research-Practice’ Encounters in.
COVASNA COUNTY’S SOCIAL SERVICES FOR DISABLED PERSONS dr.Tatár Márta - county councillor Vass Mária head of the Covasna County Social and Child Care Directorate.
“Hospital Information System: A Transition to a Health Information System” Kiki Tsitoyanni Presales Manager Soren Hayrabedyan Consultant H-SYSTEMS, Health.
Drug use, related problems and interventions targeting drug users in prison in the European countries: main issues and challenges for the future Linda.
EYES ON THE FUTURE Be part of the Solution Come to debate and innovate ! 12 th EFTC CONGRES The Hague, The Netherlands 2 nd – 5 th June 2009.
Model regulations on demand reduction in Europe Bylaw on drug demand reduction.
HEALTH EDUCATION Věra Kernová National Institute of Public Health Prague.
Milieu Therapy— The Therapeutic Community
Substance Abuse Treatment. PROFILE OF A DRUG ABUSER  MOST PEOPLE IN TREATMENT ARE BETWEEN YEARS OF AGE  MANY DRUG ABUSERS SUFFER FROM MENTAL HEALTH.
National Bureau for Drug Prevention How to improve quality of treatment services: the perspectives of Pompidou Group Piotr Jabłonski Director of National.
The involvement of patients in Health Technology Assessment Andrzej Rys Director Health and Consumers Directorate-General Brussels 18 May 2010.
An EMCDDA view on recovery Roland Simon Head of Unit Intervention, Best Practice, and Scientific Partners.
Municipal Drug Policy Legislation, institutions and programs Assoc. Prof. Hristo Bozov, MD, PhD Deputy-Mayor of Municipality of Varna Chairman of Municipal.
Essential elements for regulation Bylaw on drug demand reduction.
WORK PACKAGE TREATMENT CHALLENGES Dr.Thomas Legl Member of Executive Committee EURO –TC Director Kur- und Gesundheitszentrum Knappenhof/Austria ICAA,,
SUBSTANCE USE DISORDERS GENERAL METHODS OF TREATMENT Inpatient Detoxification and Rehabilitation Outpatient Individual, Couple, or Family Counseling Self-help.
Jennifer Hillebrand, „Rehabilitation of Drug Addicted Persons: Experience of Lithuania and European Countries”, 18 October 2007 Improving drug treatment.
Treatment system-based data collection: an integrated approach to monitoring Expert meeting: Implementation of the treatment strategy EMCDDA Lisbon,
CO-MORBITITY RESEARCH IN ADDICTION SCIENCE International Round Table ICAA MEETING MAGDEBURG May 23 rd, 2008 DR. THOMAS LEGL KUR UND GESUNDHEITSZENTRUM.
MAXIMIZING MENTAL HEALTH PARTNERSHIPS Doreen Bradshaw, Executive Director Shasta Consortium of Community Health Centers.
Drink Drivers Rehabilitation Systems Birgit Bukasa.
Mental Health and Substance Abuse Services Joe Vesowate Assistant Commissioner.
The Addiction Severity Index (ASI) Across Cultures TRI science addiction 2005 NIDA International Forum June 17th, 2005 Workshop II - The Ireland Room B.
Annual report 2010: the state of the drugs problem in Europe.
DEMOCRACY, CITIES AND DRUGS II Thematic Platforms Presentation Stephane Leclercq Safer Nightlife platform Presentation ABD – Energy Control ABD: Asociación.
DEMOCRACY, CITIES AND DRUGS II Thematic Platforms Presentation Safer Nightlife platform Presentation ABD – Energy Control ABD: Asociación Bienestar y Desarrollo.
Security, Democracy & Cities Security, Democracy & Cities Democracy,
Chapter 3 Addictions: Theory and Treatment. Drug Addiction Behavioral pattern of drug use Overwhelming involvement Securing of its supply Tendency to.
Towards a European network for digital preservation Ideas for a proposal Mariella Guercio, University of Urbino.
Twinning Project Implementation of Strategy for Fight Against Drugs in Serbia Kick off and Assessment November 2012 Belgrade.
DEMOCRACY, CITIES AND DRUGS II Thematic Platforms Presentation Young wanderers and drugs Presentation ANIT is the French federation of health centres and.
Arash Ghodousi Addiction Therapy 2015 Florida, USA August 03-08, 2015.
Paul Griffiths and Roland Simon Wrap-up presentation What has the EMCDDA learned ?
Integrated Approach towards Investing in Children
Services Overview: Mental Health/Substance Use Disorders Programs and Managed Care Plans 1 Medi-Cal Managed Care Plans (MCP) County Mental Health Plan.
Linda Montanari, Buenos Aires, October 2003 CICAD/OAS, Demand Reduction Experts Group Meeting The Information System on Treatment Demand in EU EMCDDA.
Delivery Systems for Substance Abuse Treatment: Integration with Primary Care and Mental Health and Social Services (Also referred to as) Delivery Systems.
Module 1 General introduction to substitution treatment.
Eurocare recommendations for a future EU alcohol strategy June 2012.
Addiction Treatment in Israel: An Overview of Services Provision Iris Mordecovitch, MSW.
Scottish Drugs Forum Glasgow 30th June 2005 Residential Drug Services – Where do they fit on the treatment map? The situation in Switzerland Nicolas Heller.
Integrating Mental Health and Psychosocial Interventions into World Bank Lending for Conflict Affected Populations: A Toolkit About the Toolkit: Provides.
METHADONE VS. NON-METHADONE PATIENTS IN A THERAPEUTIC COMMUNITY: TEST OF EQUIVALENCY James L. Sorensen 1,2, S. Andrews 1,2, K. L. Delucchi 1,3, B. Greenberg.
TREATMENT OF SUBSTANCE USE DISORDERS TX myths 1. Nothing works 2. One approach is superior to all others (“one true light” tradition) 3. All treatment.
By Fred Kigozi M.D WPA Zone 14 Representative/ President Uganda Psychiatric Association, Director Butabika Hospital or
Delivery Systems for Substance Abuse Treatment Country Presentation - Slovakia Lubomir Okruhlica, M.D., Ph.D. Institute on Drug Dependencies, CTDD Bratislava.
Substance Abuse Spring Substance-Related Disorders Substance abuse Substance dependence –Tolerance –Withdrawal Substance intoxication 2 Define substance.
BULGARIAN NATIONAL STRATEGY FOR COMBATING DRUG ABUSE Reporter: Yuri Katsarov /01 – 02 October 2015/ City of Reykjavik Promoting the bilateral.
Double Diagnosis /da Vinci / Biomed /VIENNA EMERGING SERVICE MODELS IN MENTAL HEALTH AND INTELLECTUAL DISABILITY IN THE CITY OF VIENNA Ernst Berger.
Overview of KP Behavioral Health Delivery System Dr. Stuart Buttlaire Regional Director of Inpatient Psychiatry and Continuing Care Regional Chair, Integrated.
Monitoring and reporting on the drug phenomenon in Europe EMCDDA mandate and activities Wolfgang Götz, Scientific Committee, Palmela, 14 February 2008.
The 7th Framework Programme for Research: Strategy of international cooperation activities Robert Burmanjer Head of Unit, “International Scientific Cooperation.
DEMOCRACY, CITIES AND DRUGS II Project French National Platform.
PUBLIC-PRIVATE GOVERNANCE IN DRUG-USERS REHABILITATION AND RECOVERY Member of Italian Council of the Department of Antidrug Policies at Italian Presidency.
5th Working Group Meeting of the Fund for Bilateral Relations at National Level Programme CZ11 Public Health Inititatives Activities Proposal Prague, 9.
CHAPTER 8: Group Treatment Substance Abuse Counseling: Theory and Practice Fifth Edition Patricia Stevens Robert L. Smith Prepared by: Dr. Susan Rose,
Drug addiction: Therapeutic problems in everyday clinical practice
Behavioral Health of Cambria County
German Drug and Addiction Policy
SEID - Project Feasibility study of the Key Pilot Action Prevention (Kethea PLEFSI) Synthesis of the questionnaires.
Dr. Wilfried Kunstmann - German Medical Association - Berlin
Substance-Related Disorders Part II
Presentation transcript:

WORK PACKAGE TREATMENT CHALLENGES Dr.Thomas Legl Member of Executive Committee EURO –TC Director Kur- und Gesundheitszentrum Knappenhof/Austria ICAA,, Vienna NGO Committe on Narcotic Drugs DEMOCRACY CITIES AND DRUGS II Kick-off Seminar Paris, June 2008

OBJECTIVES  To identify actual challenges in treatment  To find responses to local specifities and actual consumption patterns  To develop best strategy for the local city level  To promote exchange to other stakeholders  To make treatment easier accessible and more attractive to the persons in need

PLATFORM LEADER - EURO-TC  Network of addiction treatment centers  Covers 9 european countries  Special promotion of: Flexible therapeutic programmes fitting the patients needs Flexible therapeutic programmes fitting the patients needs Integrated treatment programmes for special target groups Integrated treatment programmes for special target groups  Exchange on the scientific level as well as on the level of clients activities

WORK AGENDA  Implementation seminar Bucharest / establishment of scientific group and work plan  Development of a questionnaire to evaluate a status quo  Analyze the questionnaire  2 workshops organized by the scientific group  5 refinement meetings  Development of guidelines

BACKGROUND/GENERAL GUIDELINES WITHIN THE EU  Integrative Approach  Different Problems – Different Strategies  Punishment for Trafficking & Treatment for Dependant Persons  Counseling Consumers  Decriminalization vs. Legalization

SITUATION  Rapid Development of Substitution Programmes  Traditional Abstinent Treatment / Need for flexible interventions

Co-Morbidity - Flow Pattern Psychiatric Hospital Outpatient Facility TC Substitution Programme High Co-Morbitity Low Co-Morbitity High Co-Morbitity Low Co-Morbitity

SUBSTIUTION TREATMENT  Italy 27-29%  Spain 41-86%  90% Methadone – Methadone patients in Europe BEST PRACTICE  Long term basis and effective dosage  Psychosocial treatment  Excellent experience in combination with residential treatment

Substitution drugs  Very different legal situation within European countries  Methadone – Buprenorphine  Heroine maintenance – “perfect administration”  Matching treatment towards clients needs  special target groups / Vienna experience

MATCHING TREATMENT TO THE PATIENTS NEEDS SPECIAL PROGRAMMES  Parents and Children  Dual Diagnosis  Adolescents  Gender Oriented Treatment  Ethnic Approach  Geriatric Communities

CHANGE IN CONSUMPTION PATTERNS WHAT IST THE ANSWER TO  Increasing consumption of cocaine  Increasing consumption of methamphetamines  Parallel -consumption of alcohol and stimulants in substitution programs

NECESSITIES  Different settings for different types  Anonymity essential  Time factor needs focusing on behavioral aspects

CHALLENGES  ADAPTING TREATMENT TO PATIENTS NEEDS  Needs emerge during therapy  Matching needs as they emerge  Treatment not limited to a single inpatient intervention  very clear for non-addiction diagnoses  Making treatment attractive

THANK YOU FOR YOUR ATTENTION